mail2

Spectrum Library

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Publication Date December 2017

Bortezomib for Neuromyelitis Optica Spectrum Disorder – A Reply Letter

Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment

Publication Date October 2017

Spontaneous remission lasting more than a decade in untreated AQP4 antibody-positive NMOSD.

Publication Date May 2017

Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis.

Publication Date October 2017

Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Publication Date November 2017

Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder

Publication Date August 2017

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Publication Date October 2017

Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.

Publication Date September 2017

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients

Publication Date August 2017

Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.

Publication Date August 2017

Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it.

Publication Date March 2017

Tags
Recent Comments